Nanexa AB
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
NANEXA | ST
Overview
Corporate Details
- ISIN(s):
- SE0007074166 (+2 more)
- LEI:
- 549300J5L2ECZTLID491
- Country:
- Sweden
- Address:
- Virdings Allé 2, 754 50 Uppsala
- Website:
- https://nanexa.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Nanexa AB is a pharmaceutical company that develops long-acting injectable drugs using its proprietary PharmaShell® drug delivery system. The technology is based on Atomic Layer Deposition (ALD), a precision nanotechnology used to coat drug particles, enabling high drug loads and precisely controlled, extended-release formulations. This aims to improve treatment efficacy and patient convenience by reducing dosing frequency. The company advances its own product pipeline, including a long-acting GLP-1 formulation for type 2 diabetes (NEX-22), and also engages in collaborative projects with other pharmaceutical firms to apply its technology to their drug candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Nanexa AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nanexa AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nanexa AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
